| 1978N-0065 | Skin Bleaching Drug Products | |||||||||||||||||||||||
| FDA Comment Number : | EC177 | |||||||||||||||||||||||
| Submitter : | Mrs. Pat Bickford | Date & Time: | 12/20/2006 08:12:24 | |||||||||||||||||||||
| Organization : | Mrs. Pat Bickford | |||||||||||||||||||||||
| Category : | Drug Association | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| As a consumer of Obagi Skin products for many years,I question the need to change the parameters of being able to continue to purchase said product as the statue reads at the present. Making the products containing the ingredient in question available by prescription would increase the cost and be unavailable through your insurance company anyway. I am sure many consumers of Obagi products would like to continue being able to purchase under the present law. | ||||||||||||||||||||||||